# US 2004/0204596 A1 · Method for the preparation of unsaturated hydroxy fatty acids and their esters, their use in pharmaceutical and/or cosmetic preparations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0204596 A1
- Document ID: US20040204596A1
- Status: Published application
- Kind: A1
- Application number: 10/799,532
- Filed: 2004-03-12
- Published: 2004-10-14
- Earliest claimed: 2001-09-11
- Assignees: Pierre Potier
- Inventors: Pierre Potier; Francoise Picot; Jean-Louis Brayer
- Web page: https://patentgrep.com/patent/US20040204596A1

## CPC

- C07D 309/12: only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 19/04: for non-specific disorders of the connective tissue
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 31/04: Antibacterial agents
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 45/27: by oxidation (with ozone C07C45/40)
- C07C 59/42: containing hydroxy or O-metal groups
- C07C 67/343: by increase in the number of carbon atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

A method of preparing unsaturated hydroxy fatty acids and esters thereof corresponding to general formula (Id): 1 wherein n=1 to 4, m=2 to 16, R1═OH, Cl, Br, OR3 in which R3 is a straight or branched alkyl, alkenyl or alkynyl radical of 1 to 16 carbons or glycerol esters, optionally substituted by one or more atoms selected from the group consisting of carbon, nitrogen, sulfur and halogens, R2═H, SiR′1R′2R′3 in which R′1, R′2 and R′3 can be identical or different from each other and are a straight or branched alkyl, alkenyl or alkynyl radical of 1 to 16 carbons or glycerol esters, optionally substituted by one or more atoms selected from the group consisting of carbon, nitrogen, sulfur and halogens, or R2═C—Ar3 with Ar representing an aryl radical optionally substituted by one or more atoms selected from the group consisting of carbon, nitrogen, sulfur and halogens, or R2=the tetrahydropyranyl of formula: 2 is disclosed.

## Claims

### Claim 1

A method of preparing unsaturated hydroxy fatty acids and esters thereof corresponding to general formula (Id):
Formula (Id)
26
wherein n=1 to 4, m=2 to 16,
R1═OH, Cl, Br, OR3 in which R3 is a straight or branched alkyl, alkenyl or alkynyl radical of 1 to 16 carbons or glycerol esters, optionally substituted by one or more atoms selected from the group consisting of carbon, nitrogen, sulfur and halogens,
R2═H, SiR′1R′2R′3 in which R′1, R′2 and R′3 can be identical or different from each other and are a straight or branched alkyl, alkenyl or alkynyl radical of 1 to 16 carbons or glycerol esters, optionally substituted by one or more atoms selected from the group consisting of carbon, nitrogen, sulfur and halogens,
or R2═C—Ar3 with Ar representing an aryl radical optionally substituted by one or more atoms selected from the group consisting of carbon, nitrogen, sulfur and halogens,
or R2=the tetrahydropyranyl of formula:
27
comprising causing a series of reactions according to a reaction diagram as follows:
28
wherein R1, R2, m and n have the same meanings as in formula Id.

### Claim 2 (depends on 1)

The method according to claim 1, wherein a first step in the reaction diagram is a bromination, with an initial compound being a diol of formula (II).

### Claim 3 (depends on 2)

The method according to claim 2, wherein the first step uses a solvent.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the solvent is selected from the group consisting of toluene, benzene, dimethylformamide, tetrahydrofuran, cyclohexane, heptane and petroleum ether.

### Claim 5 (depends on 1)

The method according to claim 1, wherein a reagent used in a first step in the reaction diagram is selected from the group consisting of aqueous or nonaqueous HBr, Ph3P,Br2, carbon triphenylphosphine tetrabromide and hydrobromic acid.

### Claim 6 (depends on 1)

The method according to claim 1, wherein a second step in the reaction diagram is an oxidation in aldehyde of formula (IV) in the presence of an optionally cyclic, optionally anhydrous tertiary amine N-oxide and in the presence of DMSO.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the optionally cyclic, optionally anhydrous tertiary amine N-oxide is selected from the group consisting of N-methylmorpholine oxide, trimethylamine oxide, triethylamine oxide and mixtures thereof.

### Claim 8 (depends on 1)

The method according to claim 1, wherein a third step in the reaction diagram is a Wittig-Homer reaction and a fourth step in the reaction diagram is a saponification reaction.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the Wittig-Horner reaction is carried out in the presence of triethylphosphonoacetate and potassium carbonate.

### Claim 10 (depends on 1)

The method according to claim 1, wherein a fifth step in the reaction diagram is a specific protection of an alcohol functional group of the compound of general formula (Ib) obtained in a fourth step in the reaction diagram.

### Claim 11 (depends on 1)

The method according to claim 1, wherein a fifth step in the reaction diagram is carried out in an enol ether in the presence of an acid catalyst.

### Claim 12 (depends on 1)

The method according to claim 1, wherein a fifth step in the reaction diagram carried out with dihydropyrane in the presence of PTSA (para-toluene sulfonic acid).

### Claim 13 (depends on 1)

The method according to claim 1, wherein a product of formula (Id) obtained in a fifth step in the reaction diagram is subjected to a final deprotection to obtain the compound of general formula (Ie).

### Claim 14 (depends on 1)

The method according to claim 1, wherein a product of formula (Id) obtained in a fifth step in the reaction diagram is used in an esterification reaction of the glycerol prior to undergoing final deprotection.

### Claim 15 (depends on 13)

The method according to claim 13, wherein the deprotection is carried out in a methanol solution containing an acid catalyst.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the acid catalyst is PTSA.

### Claim 17

A method of preparing unsaturated hydroxy fatty acids and esters thereof corresponding to general formula (Id):
29
wherein n=1 to 4, m=2 to 16,
R1═OH, Cl, Br, OR3 in which R3 is a straight or branched alkyl, alkenyl or alkynyl radical of 1 to 16 carbons or glycerol esters, optionally substituted by one or more atoms selected from the group consisting of carbon, nitrogen, sulfur and halogens,
R2═H, SiR′1R′2R′3 in which R′1, R′2 and R′3 can be identical or different from each other and are a straight or branched alkyl, alkenyl or alkynyl radical of 1 to 16 carbons or glycerol esters, optionally substituted by one or more atoms selected from the group consisting of carbon, nitrogen, sulfur and halogens,
or R2═C—Ar3 with Ar representing an aryl radical optionally substituted by one or more atoms selected from the group consisting of carbon, nitrogen, sulfur and halogens,
or R2=the tetrahydropyranyl of formula:
30
comprising:
a) brominating an initial diol of formula II:
31
in an aqueous or nonaqueous solvent;
b) oxidizing a bromide formed in step (a) in the presence of an optionally cyclic, optionally anhydrous tertiary amine N-oxide in the presence of DMSO to form an aldehyde of formula IV;
c) subjecting the aldehyde formed in step (b) to a Wittig-Homer reaction;
d) subjecting the product of step (c) to saponification to form a compound of general formula Ib:
32
and
e) subjecting the compound of general formula (Ib) obtained in step (d) to a specific protection of an alcohol functional group in the presence of an acid catalyst.

### Claim 18 (depends on 17)

The method according to claim 17, wherein the solvent is selected from the group consisting of toluene, benzene, dimethylformamide, tetrahydrofuran, cyclohexane, heptane and petroleum ether.

### Claim 19 (depends on 17)

The method according to claim 17, wherein a reagent used in step (a) is selected from the group consisting of aqueous or nonaqueous HBr, Ph3P,Br2, carbon triphenylphosphine tetrabromide and hydrobromic acid.

### Claim 20 (depends on 17)

The method according to claim 17, wherein step (b) is an oxidation of an aldehyde of formula (IV) in the presence of an optionally cyclic, optionally anhydrous tertiary amine N-oxide and in the presence of DMSO.

### Claim 21 (depends on 17)

The method according to claim 17, wherein the Wittig-Homer reaction is carried out in the presence of triethylphosphonoacetate and potassium carbonate.

### Claim 22 (depends on 17)

The method according to claim 17, wherein step (e) is carried out with dihydropyrane in the presence of PTSA (para-toluene sulfonic acid).

### Claim 23 (depends on 17)

The method according to claim 17, wherein a product of formula (Id) obtained in step (e) is subjected to a final deprotection to obtain the compound of general formula (Ie).

### Claim 24 (depends on 17)

The method according to claim 17, wherein a product of formula (Id) obtained in step (e) is used in an esterification reaction of the glycerol prior to undergoing final deprotection.

### Claim 25 (depends on 17)

A method of preventing or treating degradation of collagen comprising administering a therapeutically effective amount of a compound formed according to the method of claim 17 to a patient in need.

### Claim 26 (depends on 17)

A method of preventing or treating degradation of collagen by bacterial collagenases during a bacterial infection comprising administering a therapeutically effective amount of a compound formed according to claim 17 to a patient in need.

### Claim 27 (depends on 17)

A method of regenerating skin and ligaments comprising administering a therapeutically effective amount of a compound produced according to claim 17 to a patient in need.

### Claim 28 (depends on 17)

A method of preventing or treating tumoral invasion comprising administering a therapeutically effective amount of a compound produced according to claim 17 to a patient in need.

### Claim 29 (depends on 17)

A method of preventing or treating degenerative diseases having fibrinoid degeneration of collagen comprising administering a therapeutically effective amount of a compound produced according to claim 17 to a patient in need.

### Claim 30 (depends on 17)

A method of reducing weight in a patient in need thereof comprising administering a therapeutically effective amount of a compound made according to the method of claim 17.
